ZFAS1 and endometrial carcinoma: Previous study has shown that upregulation of ZFAS1 in endometrial carcinoma predicted poor prognosis of the patients, and in vitro loss-of-functional assays validated the oncogenic role of ZFAS1 on endometrial carcinoma [13].